Global Phytosterol Market Report By Type (Beta-Sitosterol, Campesterol, Sigmasterol And Others), Application (Pharmaceuticals, Food Ingredients And Cosmetics) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210342
January 2020
Report Formats:

As per this study the Global Phytosterol Market was valued USD XXX MN (by revenue) in 2019 and is anticipated to reach USD XXX MN by 2026 with a CAGR of X.X%. By volume, the market was estimated XXX Tons in 2019 and is expected to reach XXX Tons by 2026 with a CAGR of X.X%.

Phytosterol is the plant-based steroid (triterpene), an essential component of the plant cell membrane that structurally resembles cholesterol. These are abundantly found in seeds, legumes, unrefined oils whereas relatively less quantity of phytosterol is found in grains, nuts, olives and vegetables. These are insoluble in water but are soluble in alcohols. Consumption of phytosterol leads to a reduction in cholesterol absorption and improves fat circulation.

Market Dynamics
 
The market is projected to gain fast paced growth owing to health benefits associated with phytosterol.  Approval by various regulatory agencies such as FDA, EFSA and others for consumption of phytosterol to reduce blood cholesterol level is again pushing the market growth. Phytosterol aids in regulating brain functioning and heart rate is again boosting the demand from the pharmaceutical sector.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of phytosterol.
 
Market Segmentation
 
The broad phytosterol market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Beta-Sitosterol
  • Campesterol
  • Sigmasterol
  • Others
 
By Application
  • Pharmaceuticals
  • Food Ingredients
  • Cosmetics
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for phytosterol in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Phytosterol Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the phytosterol market include Arboris, LLC, Archer Daniels Midland Business (ADM), BASF Cognis, Cargill, Inc, Dérivés Résiniques et Terpéniques (DRT), DuPont Danisco, Enzymotec Ltd., Eugene Science, Inc., Fenchem Enterprises Ltd., Forbes Medi-Tech Corp., Lipofoods, Phyto-Source, L.P., PrimaPharm B.V., Raisio Group and Triple Crown AB. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 

METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       2.2. Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Snapshot
 
3 . BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.3. Market Restraints of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.4. Opportunities of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.5. Trends of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.6. Porter’s Five Force Analysis of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.7. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Therapy
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Value Chain Analysis
       4.2. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product
       5.3 Market Analysis of Alpha Blockers by Regions
       5.4 Market Analysis of 5-Alpha Reductase Inhibitor by Regions
       5.5 Market Analysis of Phosphodiesterase-5 Inhibitors by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY THERAPY
       6.1 Overview by Therapy
       6.2 Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Therapy
       6.3 Market Analysis of Monodrug Therapy by Regions
       6.4 Market Analysis of Combination Therapy by Regions
 
7 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.3.3. North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.4.3. Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.5.3. Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.6.3. Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.7.3. Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT COMPANIES
       8.1. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Abbott Laboratories
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Allergan plc
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Astellas Pharma Inc.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Boehringer Ingelheim Pharma GmbH & Co. KG
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Eli Lilly and Company
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. GlaxoSmithKline plc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Merck & Co., Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Pfizer Inc.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Sanofi
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Teva Pharmaceutical Industries Limited
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Snapshot
  • Drivers of The Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Impact Analysis
  • Restraints of The Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Alpha Blockers by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in 5-Alpha Reductase Inhibitor by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Phosphodiesterase-5 Inhibitors by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Others by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Therapy (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Monodrug Therapy by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Combination Therapy by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Geography (USD MN)
  • North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • United State Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • United State Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • United Kingdom Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • United Kingdom Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • France Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • France Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Germany Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Germany Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • China Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • China Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Japan Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Japan Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • India Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • India Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • Brazil Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Brazil Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • Middle East Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Middle East Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Alpha Blockers by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in 5-Alpha Reductase Inhibitor by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Phosphodiesterase-5 Inhibitors by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Others by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Therapy (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Monodrug Therapy by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Combination Therapy by Geography (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Revenue
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Revenue
  • Recent Development in Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials